Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.7002
-0.02-2.72%
At close: -
$0.7300
0.034.26%
After Hours: May 9, 7:55 PM EDT
Comments
Loading...
Sangamo Therapeutics Stock Price, Quotes and Forecasts
SGMONASDAQ
Sangamo Therapeutics (SGMO) Forecast
NewsEarningsSangamo Therapeutics (SGMO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sangamo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SGMO | Benzinga
Explore Sangamo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SGMO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sangamo Therapeutics (SGMO) stock?
You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.
Who are Sangamo Therapeutics (SGMO) competitors?
Other companies in Sangamo Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Quoin Pharmaceuticals (NASDAQ:QNRX), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Sangamo Therapeutics (SGMO) stock?
Sangamo Therapeutics has a consensus price target of $5.17.
What is the current price for Sangamo Therapeutics (SGMO)?
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.73 last updated May 9, 2025 at 7:55 PM EDT.
Does Sangamo Therapeutics (SGMO) pay a dividend?
There are no upcoming dividends for Sangamo Therapeutics.
When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?
Sangamo Therapeutics’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is Sangamo Therapeutics (SGMO) going to split?
There is no upcoming split for Sangamo Therapeutics.
What sector and industry does Sangamo Therapeutics (SGMO) operate in?
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
